The Tuberculosis Diagnostics Market is Predict to reach USD 3.0 Billion by 2031, at a CAGR of 4.7%
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Tuberculosis Diagnostics Market Growth, Trends and Report Highlights
According to a new report, published by KBV research, The Global Tuberculosis Diagnostics Market size is expected to reach $3 billion by 2031, rising at a market growth of 4.7% CAGR during the forecast period.
The Diagnostic Laboratories segment led the Global Tuberculosis Diagnostics Market by End Use in 2023; thereby, achieving a market value of $1.31 billion by 2031. Diagnostic laboratories are the primary centers for administering comprehensive TB tests, including molecular diagnostics, culture, and drug susceptibility testing (DST), due to their advanced technologies and specialized personnel.
The Diagnostic Laboratories segment led the Global Tuberculosis Diagnostics Market by End Use in 2023; thereby, achieving a market value of $1.31 billion by 2031. Diagnostic laboratories are the primary centers for administering comprehensive TB tests, including molecular diagnostics, culture, and drug susceptibility testing (DST), due to their advanced technologies and specialized personnel.
The Detection of Latent Infection (Skin Test & IGRA) segment is growing at a CAGR of 4.1 % during the forecast period. This dominant position can be attributed to the extensive use of these tests in screening programs, particularly among high-risk populations such as healthcare personnel and individuals with compromised immune systems.
Full Report: https://www.kbvresearch.com/tuberculosis-diagnostics-market/
The North America region dominated the Global Tuberculosis Diagnostics Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $885 million by 2031. The Europe region is anticipated to grow at a CAGR of 4.4% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 5.2% during (2024 - 2031).
List of Key Companies Profiled
- Abbott Laboratories
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- F.Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- Bruker Corporation
Tuberculosis Diagnostics Market Report Segmentation
By End Use
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
By Type
- Detection of Latent Infection (Skin Test & IGRA)
- Phage Assay
- Detection of Drug Resistance (DST)
- Nucleic Acid Testing
- Radiographic Method
- Cytokine Detection Assay
- Diagnostic Laboratory Methods
- Other Methods
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Related Reports:
Asia Pacific Tuberculosis Diagnostics Market Size, Share 2031
- August-2024
- 122 Pages
North America Tuberculosis Diagnostics Market Size to 2031
- August-2024
- 113 Pages
LAMEA Tuberculosis Diagnostics Market Size | Analysis 2031
- August-2024
- 122 Pages
Europe Tuberculosis Diagnostics Market Size | Forecast 2031
- August-2024
- 122 Pages